Guidelines for Neuroleptic Relapse Prevention in Schizophrenia

Proceedings of a Consensus Conference held April 19–20, 1989, in Bruges, Belgium

  • Werner Kissling

Table of contents

  1. Front Matter
    Pages I-IX
  2. Introduction

    1. W. Kissling
      Pages 1-6
  3. Relapse Prevention in Different Countries: The Current Situation

  4. Reviews of the Literature

About these proceedings

Introduction

How neuroleptics are used in relapse prevention is a very controversial topic. Fifty percent of all schizo- phrenic patients do not receive sufficient prophylactic treatment and suffer from frequent relapses. To help correct this situation, leading international experts in the field of neuroleptic relapse prevention (n.r.p.) agreed upon guidelines after intensive discussions at a consensus workshop in Bruges in April 1989. Precise guidelines to the most important questions on n.r.p. are formu- lated, especially concerning indications, treatment duration and dosage. The current state of the literature on these questions is presented in comprehensive reviews. For the practicing psychiatrist or general practitioner, exact guidelines for prophylactic treatment are presented; for patients and their families eager to obtain more information, the scientific basis of the treatment is explained.

Keywords

Epilepsie Schizophrenia Schizophrenie epilepsy prevention therapy

Editors and affiliations

  • Werner Kissling
    • 1
  1. 1.Psychiatrische Klinik und PoliklinikTechnischen Universität MünchenMünchen 80Germany

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-642-86922-8
  • Copyright Information Springer-Verlag Berlin Heidelberg 1991
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Springer Book Archive
  • Print ISBN 978-3-540-53985-8
  • Online ISBN 978-3-642-86922-8
  • About this book